Satisfacción y preferencia del paciente asmático por los dispositivos de inhalación. Aplicación del FSI-10

Tordera, Miguel Perpiñá; Viejo, José Luís; Sanchís, J.; Badı́a, Xavier; Cobos, N.; Picado, César; Sobradillo, V.; Río, Jaime Martínez González del; Duce, F.; Cabrera, Luís Muñoz

doi:10.1157/13124581

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We assessed if any changes to inhalers made at the point of discharge were continued in the community. Participants were asked about satisfaction with their inhalers using the Feeling of Satisfaction with Inhaler (FSI-10) questionnaire [ 10 ] consisting of 10 questions on a five-point Likert scale with a maximum score of 50 and minimum score of 10, with a higher score representing greater satisfaction with the inhaler. Where people were on more than one preventative inhaler, we used the mean of the two scores.…”

Section: Methodsmentioning

confidence: 99%

Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD

Price,

Ahmad,

Althobiani

et al. 2024

ERJ Open Res

View full text Add to dashboard Cite

INTRODUCTIONMortality and re-admissions after a hospitalised exacerbation of chronic obstructive pulmonary disease (COPD) are high and resistant to change. COPD guidelines do not give practical advice about the optimal selection of inhaled drugs and device in this situation. We hypothesised that a failure to optimise inhaled drug and drug delivery prior to discharge from hospital after an exacerbation would be associated with a modifiable increased risk of re-admission and death. We designed a study to (i) develop a practical inhaler selection tool to use at the point of hospital discharge and (ii) implement this tool to understand the potential impact on modifying inhaler prescriptions, clinical outcomes, acceptability to clinicians and patients, and the feasibility of delivering a definitive trial to demonstrate potential benefit.METHODSWe iteratively developed an inhaler selection tool for use prior to discharge following a hospitalised exacerbation of COPD using surveys with multi-professional clinicians and a focus group of people living with COPD. We surveyed clinicians to understand their views on the minimum clinically important difference (MCID) for death and re-admission following a hospitalised exacerbation of COPD. We conducted a mixed methods implementation feasibility study using the tool at discharge, and collated 30- and 90-day follow-up data including death and re-admissions. Additional we observed the tool being used and interviewed clinicians and patients about use of the tool in this setting.RESULTSWe completed the design of an inhaler selection tool through two rounds of consultations with 94 multi-professional clinicians, and a focus group of four expert patients. Regarding MCIDs, there was majority consensus for the following reductions from baseline being the MCID: 30-day readmissions 5–10%, 90-day readmissions 10–20%, 30-day mortality 5–10% and 90-day mortality 5–10%. 118 patients were assessed for eligibility and 26 had the tool applied. A change in inhaled medication was recommended in 9/26 (35%). Re-admission or death at 30 days was seen in 33% of the switch group and 35% of the no-switch group. Re-admission or death at 90 days was seen in 56% of the switch group and 41% of the no-switch group. Satisfaction with inhalers was generally high, and switching was associated with a small increase in the Feeling of Satisfaction with Inhaler questionnaire (FSI) questionnaire of 3/50 points. Delivery of a definitive study would be challenging.CONCLUSIONWe completed a mixed-methods study to design and implement a tool to aid optimisation of inhaled pharmacotherapy prior to discharge following a hospitalised exacerbation of COPD. This was not associated with fewer re-admissions, but was well received and one third of people were eligible for a change in inhalers.

show abstract

Section: Methodsmentioning

confidence: 99%

Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD

Price,

Ahmad,

Althobiani

et al. 2024

ERJ Open Res

View full text Add to dashboard Cite

show abstract

“…Supplementary Table 2 shows the questions contained in the instrument. 14 An FSI-10 ≥44 points was considered high satisfaction. 15 , 16 Comedications: They were grouped into the following categories: a) antidiabetic drugs (oral and subcutaneous), b) antihypertensive and diuretic drugs, c) lipid-lowering drugs, d) antiulcer drugs, e) antidepressants, f) anxiolytics and hypnotics, g) thyroid hormone, h) antipsychotics, i) antiepileptics, j) antithrombotics, and k) analgesics and anti-inflammatories, among others.…”

Section: Methodsmentioning

confidence: 99%

“…Supplementary Table 2 shows the questions contained in the instrument. 14 An FSI-10 ≥44 points was considered high satisfaction. 15 , 16 …”

Section: Methodsmentioning

confidence: 99%

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease

Valladales-Restrepo,

Oyuela-Gutiérrez,

Delgado-Araujo

et al. 2023

PPA

View full text Add to dashboard Cite

Purpose Chronic obstructive pulmonary disease (COPD) affects millions of people around the world. Poor adherence to treatment contributes to increased severity of symptoms, morbidity, and mortality. The objective of this study was to establish the adherence of patients diagnosed with COPD by their devices for inhalation in a group of patients, Colombia. Patients and Methods This was a cross-sectional study of patients treated in the Colombian health system. Adherence to inhalation devices was evaluated with the TAI-10 instrument (Inhaler Adherence Test). A score of 50 points was considered good adherence. Results A total of 500 patients from 84 cities were identified, with a median age of 79.0 years, and 59.2% were women. A total of 45% had GOLD B COPD, and 56.6% had good adherence. Average adherence was 47.4±5.3 points, and no significant differences were found according to inhalation devices (p=0.949). Training performed by specialist physicians (OR: 1.75; 95% CI: 1.17–2.62), use of an inhaler for less than 1 year (OR: 1.59; 95% CI: 1.04–2.43), use of short-acting β2-adrenergic agonists (OR: 1.58; 95% CI: 1.05–2.38) and increased satisfaction with the inhalation device (OR: 1.09; 95% CI: 1.04–1.14) were associated with good adherence, while those from the central region (OR: 0.55; 95% CI: 0.36–0.83), who had a COPD evolution time of less than 5 years (OR: 0.57; 95% CI: 0.37–0.98) and had diabetes mellitus (OR: 0.60; 95% CI: 0.37–0.98) had lower adherence. Conclusion Adherence to treatment with inhaled bronchodilators and glucocorticoids were not very high, with no significant differences by type of inhalation device. Satisfaction and training by specialists increased adherence.

show abstract

Satisfacción y preferencia del paciente asmático por los dispositivos de inhalación. Aplicación del FSI-10

Abstract: The FSI-10 is a useful instrument for assessing the degree of satisfaction of asthmatic patients regarding available inhalation devices. It is easy to understand and complete, and able to identify differences in patient satisfaction with the different inhalers.

Cited by 2 publications

References 0 publications

Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD

Development and evaluation of a tool to optimise inhaler selection prior to hospital discharge following an exacerbation of COPD

Adherence to Inhalation Devices in Patients with Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About